Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
European Medicines Agency
Pharma
Key drugs from Merck, Bayer and Gilead win EMA backing
Merck's Welireg, Bayer and BridgeBio's acoramidis, and Gilead's liver drug from its CymaBay buyout won EMA backing, while Takeda is pulling Alofisel.
Angus Liu
Dec 13, 2024 10:33am
Regulatory tracker: FDA raises safety flag on Intercept's Ocaliva
Dec 13, 2024 9:35am
EU regulators endorse meds from BMS, J&J, Eisai and more
Nov 15, 2024 10:05am
EMA changes tune, endorses Leqembi with restriction
Nov 14, 2024 12:10pm
J&J angles Darzalex for first move into early-stage myeloma
Nov 8, 2024 9:53am
Astellas pulls application for Izervay after talks with CHMP
Oct 28, 2024 11:07am
